This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Two months after U.S. President Donald Trump proclaimed DEI programs “illegal an...
After a federal guilty plea in 2020, the former OxyContin drugmaker is required ...
After charting similar moves throughout 2024, Pfizer this week completed a sale ...
The campaign asks why people readily pick up their dogs’ poop while putting off ...
A pair of clinical data sets gives Novartis confidence in a new formulation of t...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
As the college basketball March Madness tournament tips off this week, so too do...
One patient with Duchenne muscular dystrophy has passed away following treatment...
Fresh off a pivot from commercial pharma business to preclinical biotech, Aadi B...
With the fate of the BIOSECURE Act currently in limbo, WuXi AppTec is looking on...
In a proposed amicus brief, Eli Lilly, Johnson & Johnson, Pfizer and Sanofi have...
All of the drugmakers that market the 15 drugs selected for the second cycle of ...
Novartis is laying off 427 employees in East Hanover, New Jersey, where the comp...
One patient with Duchenne muscular dystrophy has passed away following treatment...
Novartis is laying off 427 employees in East Hanover, New Jersey, where the comp...
Klick Health is kicking up its expansion in the Asia-Pacific region. Less than t...
Under one of two policy tools that the U.K. uses to control drug costs, the Brit...
The FDA chief counsel pick quickly attracted controversy due to her prior defens...
The company revealed a plan to shutter the site back in March of 2022. Now, more...
A trio of drugmakers have issued separate recalls in the U.S. thanks to string o...
AstraZeneca has signed two deals worth $1.35 billion with Alteogen to developmen...
Novo Nordisk has been accepted back into the fold. Two years after suspending No...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...